NZ502862A - Optically pure camptothecin analogues, optically pure synthesis intermediate and method for preparing same - Google Patents

Optically pure camptothecin analogues, optically pure synthesis intermediate and method for preparing same

Info

Publication number
NZ502862A
NZ502862A NZ502862A NZ50286298A NZ502862A NZ 502862 A NZ502862 A NZ 502862A NZ 502862 A NZ502862 A NZ 502862A NZ 50286298 A NZ50286298 A NZ 50286298A NZ 502862 A NZ502862 A NZ 502862A
Authority
NZ
New Zealand
Prior art keywords
optically pure
preparing same
synthesis intermediate
camptothecin analogues
camptothecin
Prior art date
Application number
NZ502862A
Inventor
Jean-Bernard Cazaux
Olivier Lavergne
Breton Christine Le
Eric Manginot
Dennis Bigg
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of NZ502862A publication Critical patent/NZ502862A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

An analogue of camptothecin characterized in that it possesses one of the general formulae (I) or (II). These analogues of camptothecin can be used for producing antitumoral, antiviral or antiparasitic medicines.
NZ502862A 1997-08-29 1998-08-07 Optically pure camptothecin analogues, optically pure synthesis intermediate and method for preparing same NZ502862A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9710785A FR2768431B1 (en) 1997-08-29 1997-08-29 NOVEL OPTICALLY PURE CAMPTOTHECIN ANALOGS, A NEW OPTICALLY PURE SYNTHESIS INTERMEDIATE AND PROCESS FOR PREPARING THE SAME
PCT/FR1998/001768 WO1999011646A1 (en) 1997-08-29 1998-08-07 Optically pure camptothecin analogues, optically pure synthesis intermediate and method for preparing same

Publications (1)

Publication Number Publication Date
NZ502862A true NZ502862A (en) 2002-10-25

Family

ID=9510590

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ502862A NZ502862A (en) 1997-08-29 1998-08-07 Optically pure camptothecin analogues, optically pure synthesis intermediate and method for preparing same

Country Status (26)

Country Link
EP (2) EP1378512A1 (en)
JP (1) JP2001514261A (en)
KR (1) KR100570254B1 (en)
CN (3) CN1104434C (en)
AR (1) AR016856A1 (en)
AT (1) ATE253069T1 (en)
AU (1) AU760863B2 (en)
BR (1) BR9811405A (en)
CA (1) CA2301739C (en)
CZ (1) CZ297896B6 (en)
DE (1) DE69819340T2 (en)
DK (1) DK1007527T3 (en)
ES (1) ES2209196T3 (en)
FR (1) FR2768431B1 (en)
HK (2) HK1031732A1 (en)
HR (1) HRP20000110A2 (en)
HU (1) HUP0003429A3 (en)
IL (2) IL134437A0 (en)
NO (1) NO324882B1 (en)
NZ (1) NZ502862A (en)
PL (1) PL195289B1 (en)
PT (1) PT1007527E (en)
RU (1) RU2233283C2 (en)
TW (1) TW419479B (en)
WO (1) WO1999011646A1 (en)
ZA (1) ZA987445B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790261B1 (en) * 1999-02-26 2004-09-10 Sod Conseils Rech Applic NOVEL OPTICALLY PURE CAMPTOTHECIN ANALOGS AND PROCESSES FOR THEIR PREPARATION
US6207832B1 (en) 1999-04-09 2001-03-27 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
US6372906B1 (en) 2001-04-12 2002-04-16 University Of Pittsburgh Synthesis of silyl camptothecins and silyl homocamptothecins
US6723853B2 (en) 2001-08-27 2004-04-20 University Of Pittsburgh Intermediates and methods of preparation of intermediates in the enantiomeric synthesis of (20R)homocamptothecins and the enantiomeric synthesis of (20R)homocamptothecins
CN100408582C (en) * 2004-02-12 2008-08-06 中国人民解放军第二军医大学 Homocamptoth-ecine compounds, their preparation process and use
WO2006033011A1 (en) * 2004-09-21 2006-03-30 Societe De Conseils De Recherches Et D'applications Scientifique (S.C.R.A.S.) Novel processes for the production of useful intermediates
CN100465175C (en) * 2005-11-29 2009-03-04 中国人民解放军第二军医大学 7-bit substituted comptothecine kind compound and pharmaceutical use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459269A (en) * 1992-06-18 1995-10-17 North Carolina State University 14-halo-camptothecins
KR100440838B1 (en) * 1995-06-21 2004-12-17 소시에떼 드 꽁세이으 드 르세르세 에 따블리까시옹 시앙띠피끄 (에스.세.에르.아.에스.) Novel Camptothecin Analogues, Preparation Methods Therefor, Use Thereof as Drugs, and Pharmaceutical Compositions Containing Said Analogues

Also Published As

Publication number Publication date
EP1007527B1 (en) 2003-10-29
CN1440973A (en) 2003-09-10
HRP20000110A2 (en) 2001-02-28
HK1031732A1 (en) 2001-06-22
NO324882B1 (en) 2007-12-27
IL134437A0 (en) 2001-04-30
KR20010023394A (en) 2001-03-26
HUP0003429A1 (en) 2001-07-30
AR016856A1 (en) 2001-08-01
CA2301739A1 (en) 1999-03-11
AU760863B2 (en) 2003-05-22
ES2209196T3 (en) 2004-06-16
AU8989698A (en) 1999-03-22
HUP0003429A3 (en) 2002-11-28
RU2233283C2 (en) 2004-07-27
PL195289B1 (en) 2007-08-31
CZ297896B6 (en) 2007-04-25
ATE253069T1 (en) 2003-11-15
WO1999011646A1 (en) 1999-03-11
JP2001514261A (en) 2001-09-11
NO20000995L (en) 2000-02-28
CN1268948A (en) 2000-10-04
TW419479B (en) 2001-01-21
CA2301739C (en) 2009-11-17
CZ2000711A3 (en) 2000-08-16
CN1195758C (en) 2005-04-06
IL134437A (en) 2006-08-01
EP1007527A1 (en) 2000-06-14
KR100570254B1 (en) 2006-04-12
CN1104434C (en) 2003-04-02
DE69819340D1 (en) 2003-12-04
NO20000995D0 (en) 2000-02-28
FR2768431B1 (en) 2000-03-24
PL338835A1 (en) 2000-11-20
HK1058665A1 (en) 2004-05-28
CN1440972A (en) 2003-09-10
DE69819340T2 (en) 2004-08-19
DK1007527T3 (en) 2004-03-08
EP1378512A1 (en) 2004-01-07
FR2768431A1 (en) 1999-03-19
ZA987445B (en) 1999-02-17
PT1007527E (en) 2004-03-31
BR9811405A (en) 2000-08-29

Similar Documents

Publication Publication Date Title
IL130964A0 (en) Practical in vitro sialylation of recombinant glycoproteins
CA2075060A1 (en) Novel vehicle gases and their use in medical preparations
AU3939893A (en) Induction of somatic embryogenesis in (taxus), and the production of taxane-ring containing alkaloids therefrom
IL110091A0 (en) Imidazo [4,5-c] pyridin-4-amines and pharmaceutical compositions containing them
DE69716135D1 (en) In 6-position durch thio substituierte paclitaxele
PL297610A1 (en)
GR3034190T3 (en) Reconstituted cartilage tissue.
BG103664A (en) Pharmaceutical forms containing ammoxycillin and clavulanate
PL340890A1 (en) Adamantane derivatives
PL340906A1 (en) Adamantane derivatives
ATA195588A (en) EPIPODOPHYLLOTOXINGLUCOSIDE-4'-PHOSPHATE DERIVATIVES THE PRODUCTION THEREOF, AND PHARMACEUTICAL COMPOSITIONS THEREOF
IL98025A0 (en) 1,3-oxathiolane nucleoside analogues,methods for the preparation thereof and pharmaceutical compositions containing the same
BG101139A (en) Heteroatoms-containing cyclopentanopyridyloxazolidinons
HUT53521A (en) Process for producing pharmaceutical compositions comprising morphine
EP0657403A4 (en) Porous ceramic and process for producing the same.
EP0594994A3 (en) Semiconductor diamond and process for producing the same.
EP0660138A3 (en) Transparent article and process for producing the same.
HUT63063A (en) Process for producing antibodies against cd44 cell surface glycoprotein and immunosuppressant pharmaceutical compositions comprising same
BG103219A (en) Benzamidine derivatives and their application as medicamentous forms with ltb-4-antagonist effect
HU9203828D0 (en) Method for producing cristallic alpha-2-interferon
MX9602445A (en) Gilding pigments.
BG102623A (en) New derivatives of benzoylguanadine, methods for their preparation and application for the manufacture of medicamentous forms
NZ502862A (en) Optically pure camptothecin analogues, optically pure synthesis intermediate and method for preparing same
TR200001102T2 (en) Substituted tetrahydropyrimidinene derivatives, their production and uses.
DK0652635T3 (en) Differential amplification steps for use in standard bipolar ECL processes

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)